


Searching News Database: AZD-103
HSMN NewsFeed - 10 Dec 2011
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
HSMN NewsFeed - 13 Mar 2008
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
HSMN NewsFeed - 28 Dec 2007
Transition Therapeutics Announces Appointment of Vice-President of Business Development
Transition Therapeutics Announces Appointment of Vice-President of Business Development
HSMN NewsFeed - 3 Apr 2007
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
HSMN NewsFeed - 12 Sep 2006
Transition Therapeutics Appoints Andre Uddin B.Sc., Ph.D. as Vice-President of Strategic Development
Transition Therapeutics Appoints Andre Uddin B.Sc., Ph.D. as Vice-President of Strategic Development
Additional items found! 1
Members Archive contains
1 additional stories matching:
AZD-103
(Password required)
AZD-103
(Password required)
